Kazia set to raise $4m to improve cancer trials
MELBOURNE: Kazia Therapeutics will raise $4 million to improve its GDC-0084 and Cantrixil cancer programs.
MELBOURNE: Kazia Therapeutics will raise $4 million to improve its GDC-0084 and Cantrixil cancer programs.
FEATURED
Retirees are now living best lives in off-shore choice locations
More Generation X parents are funding their adult children’s lives
Four-storey residential and retail building proposed for school zone
Best social housing community design for Global Awards shortlisted
Buyer options as developer changes plan for multigenerational community
Group set to break ground on two affordable housing projects
INNOVATION
